Wealth Enhancement Advisory Services’s BioCardia BCDA Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio BCDA Stock Details BCDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$16.9K	Buy	+18,500	New	+$19.5K	﹤0.01%	4053
2026 Q1	–	Sell	-20,000	Closed	-$25.4K	–	3597
2025 Q4	$25.4K	Buy	20,000 +3,000	+18%	+$4.08K	﹤0.01%	3571
2025 Q3	$22.4K	Buy	+17,000	New	+$33.2K	﹤0.01%	3501

Other funds holding BCDA

APW

Allied Private Wealth Boca Raton, Florida $156M AUM

Wealth Enhancement Advisory Services's BCDA Position: Q2 2026 in Review

Wealth Enhancement Advisory Services opened a new position in BioCardia (BCDA) in Q2 2026: 18,500 shares worth $16.9K. The stake represents ﹤0.01% of the portfolio and ranks #4053 among its holdings. This is a return to the name: Wealth Enhancement Advisory Services previously reported a position in BCDA as recently as Q4 2025.

Wealth Enhancement Advisory Services first reported a position in BCDA in Q3 2025 and has held it in 3 quarters since. The position peaked at $25.4K in Q4 2025. 2 funds tracked by Wall St. Rank hold BCDA as of Q2 2026.

Wealth Enhancement Advisory Services held 18,500 shares of BioCardia worth $16.9K as of Q2 2026.
BioCardia was a new Wealth Enhancement Advisory Services position in Q2 2026.
BioCardia made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #4053 holding.
Wealth Enhancement Advisory Services first reported a position in BioCardia in Q3 2025 and has held it in 3 quarters since.
Wealth Enhancement Advisory Services's BioCardia position peaked at $25.4K in Q4 2025.
2 funds tracked by Wall St. Rank held BioCardia as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.